CHS Inc.
NASDAQ:CHSCLAgricultural Farm Products
-$0.05 today
- Market cap
- $294.90M
- Beta
- 0.10
- P/E (TTM)
- 0.0
- EPS (TTM)
- $0.00
- Dividend yield
- 7.37%
Volume 0.12M
Average 0.02M
CHSCL Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
CHS Inc.NASDAQ: CHSCL
Cash & Equivalents · Q2 FY2026 · quarter ended Feb 2026
Cash & equivalents falls 42.7% from a year ago
Cash & equivalents stood at $248.47M at the end of Q2 FY2026, down 42.7% from a year earlier and down 45.7% from the prior quarter. Over 3 fiscal years it compounded at -23.8% a year.
Context
- Cash & equivalents amounted to 1.2% of total assets at the end of Q2 FY2026, down 1.0 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -42.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 399.26M USD
- Year-over-year change
- -49.8%
- 4-year CAGR
- -7.4%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | 399.26M | -49.8% |
| FY2024 | 2024-08-31 | 794.87M | -56.9% |
| FY2023 | 2023-08-31 | 1.84B | +104.2% |
| FY2022 | 2022-08-31 | 903.47M | +66.5% |
| FY2021 | 2021-08-31 | 542.48M | — |
Cash & Equivalents vs competitors
How CHSCL compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -42.7% is the 8th highest of 11, against a peer median of +9.1%.
- Cash & equivalents amounts to 1.2% of total assets for CHSCL, versus a peer median of 4.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Feb 2026 | $248.47M USD | -42.7% | -23.8% | 1.2% | |
| Mar 2026 | ₪145.48M ILS | +24.5% | -6.4% | 19.5% | |
| Mar 2026 | $87.58M USD | +1.3% | +16.1% | 33.5% | |
| Mar 2026 | R$72.35M BRL | +12.8% | -28.4% | 1.9% | |
| Apr 2026 | $64.54M USD | +5.4% | +7.4% | 2.3% | |
| Mar 2026 | $52.88M USD | +260.7% | +253.2% | 26.5% | |
| Mar 2026 | $50.47M USD | +233.7% | +69.5% | 12.6% | |
AFRIForafric Global PLC | Dec 2024 | $12.23M USD | -49.1% | -16.8% | 5.0% |
| Mar 2026 | $9.97M USD | +155.5% | -51.9% | 4.6% | |
| Apr 2026 | $891K USD | -57.2% | +20.8% | 0.3% | |
SLSNSolesence, Inc. Common Stock | Mar 2026 | $573K USD | -68.5% | -16.2% | 1.2% |
| Peer median (excluding CHSCL) | — | +9.1% | +0.5% | 4.8% | |
Competitors are the stored peer set for CHSCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 542.48M | 903.47M | 1.84B | 794.87M | 399.26M |
| Short-term Investments | 0 | 0 | 0 | 500.92M | 0 |
| Net Receivables | 2.86B | 3.55B | 3.11B | 3.55B | 3.69B |
| Inventory | 3.53B | 3.85B | 3.35B | 3.2B | 3.38B |
| Other Current Assets | 1.07B | 1.07B | 677.09M | 459.6M | 420.46M |
| Total Current Assets | 8B | 9.38B | 9.13B | 8.71B | 8.09B |
| Property, Plant & Equipment (Net) | 5.06B | 4.99B | 5.12B | 5.4B | 5.74B |
| Goodwill | 171.6M | 179.98M | 179.98M | 179.98M | 239.44M |
| Intangible Assets | 58.4M | 53.17M | 46.98M | 42.11M | 94.41M |
| Long-term Investments | 3.67B | 3.78B | 3.91B | 3.88B | 3.99B |
| Tax Assets | (171.6M) | (179.98M) | (179.98M) | 0 | 0 |
| Other Non-current Assets | 786.36M | 623.46M | 750.68M | 509.82M | 709.79M |
| Total Non-current Assets | 9.58B | 9.45B | 9.83B | 10.01B | 10.78B |
| Total Assets | 17.58B | 18.82B | 18.96B | 18.72B | 18.86B |
| Account Payables | 2.62B | 3.06B | 2.93B | 2.7B | 2.72B |
| Short-term Debt | 1.84B | 952.03M | 616.86M | 867.39M | 1.31B |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 653.19M | 1.07B | 596.76M | 585.85M | 233.8M |
| Other Current Liabilities | 1.22B | 1.87B | 1.75B | 1.84B | 1.02B |
| Total Current Liabilities | 6.33B | 6.95B | 5.9B | 5.4B | 5.28B |
| Long-term Debt | 1.38B | 1.63B | 1.78B | 1.78B | 1.7B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 452.31M | 549.11M | 524.16M | 504.85M | 585.2M |
| Total Non-current Liabilities | 2.23B | 2.41B | 2.61B | 2.55B | 2.5B |
| Total Liabilities | 8.56B | 9.36B | 8.51B | 7.95B | 7.78B |
| Common Stock | 3.61B | 3.62B | 3.98B | 3.78B | 0 |
| Retained Earnings | (6.74B) | 1.85B | (15.48B) | 0 | 0 |
| Accumulated OCI | 6.74B | 7.19B | 8.18B | 4.71B | 8.81B |
| Other Stockholders Equity | 3.13B | (5.46B) | 11.5B | 0 | 0 |
| Minority Interest | 8.47M | 5.65M | 4.61M | 6.53M | 3.48M |
| Total Equity | 9.02B | 9.46B | 10.45B | 10.76B | 11.08B |
| Total Debt | 3.62B | 2.81B | 2.7B | 2.91B | 3.23B |
| Net Debt | 3.07B | 1.91B | 853.94M | 2.12B | 2.83B |
CHS Inc.
NASDAQ:CHSCL
Intrinsic Alpha fair value
Locked
Current Price
$24.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.